Signal from the log
AVAVA
45 M$ · United States · Medtech
AVAVA fabrique des appareils à énergie pour la médecine esthétique. Sa technologie Focal Point dépose l'énergie en profondeur tout en épargnant le tissu autour, ce qui doit permettre de régler le traitement selon le type de peau et la zone. Le tour mêle trente millions de dollars en capital et une ligne de dette de quinze millions.
Verified
Announced on , logged by the watch of 17 September 2026.
- Operation
- Funding round
- Announced amount
- 45 M$
- Country
- United States
- Sector
- Medtech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Catalio Capital Management
What is missing before publishing
- The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source pulse2
Logged on 17 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.